Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,505
Total Claims
$1.6M
Drug Cost
1,071
Beneficiaries
$1,484
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
-3%
Cost per patient vs peers
$1,484 vs $1,524 avg
-34%
Brand preference vs peers
9.1% vs 13.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.3%
Opioid Rate
356
Opioid Claims
$6,836
Opioid Cost
4.5%
Long-Acting Rate
Brand vs Generic
Brand: 1,399 claims · $1.3M
Generic: 14,032 claims · $331K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 402 | $563K |
| Rivaroxaban | 87 | $132K |
| Sacubitril/Valsartan | 81 | $106K |
| Empagliflozin | 48 | $73K |
| Semaglutide | 28 | $31K |
| Dronedarone Hcl | 13 | $29K |
| Metoprolol Succinate | 894 | $22K |
| Atorvastatin Calcium | 1,377 | $21K |
| Sitagliptin Phosphate | 13 | $20K |
| Budesonide/Formoterol Fumarate | 18 | $19K |
| Evolocumab | 15 | $16K |
| Ticagrelor | 23 | $14K |
| Pantoprazole Sodium | 553 | $12K |
| Dabigatran Etexilate Mesylate | 23 | $10K |
| Erenumab-Aooe | 12 | $9,687 |
Prescribing Profile
Patient Profile
74
Avg Age
52%
Female
1.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About